Reported number of people receiving antiretroviral therapy in Switzerland
Switzerland: Reported number of people receiving antiretroviral therapy was 16,146 in 2024. ▲ Rising
Reported number of people receiving antiretroviral therapy in Switzerland, 2000–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for reported number of people receiving antiretroviral therapy in Switzerland is 16,146, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 0.6% on the previous year and up 36.3% over ten years.
Over the whole period, reported number of people receiving antiretroviral therapy in Switzerland peaked at 16,146 in 2024 and was at its lowest, 3,206, in 2000.
Switzerland ranks 76th of 143 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Reported number of people receiving antiretroviral therapy in Switzerland, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 3,206 | — |
| 2001 | 3,844 | +19.9% |
| 2002 | 4,481 | +16.6% |
| 2003 | 5,118 | +14.2% |
| 2004 | 5,755 | +12.4% |
| 2005 | 6,391 | +11.1% |
| 2006 | 7,027 | +10.0% |
| 2007 | 7,665 | +9.1% |
| 2008 | 8,302 | +8.3% |
| 2009 | 8,939 | +7.7% |
| 2010 | 9,578 | +7.1% |
| 2011 | 10,211 | +6.6% |
| 2012 | 10,846 | +6.2% |
| 2013 | 11,346 | +4.6% |
| 2014 | 11,847 | +4.4% |
| 2015 | 12,355 | +4.3% |
| 2016 | 13,359 | +8.1% |
| 2017 | 14,461 | +8.2% |
| 2018 | 14,862 | +2.8% |
| 2019 | 15,057 | +1.3% |
| 2020 | 15,656 | +4.0% |
| 2021 | 15,555 | -0.6% |
| 2022 | 15,853 | +1.9% |
| 2023 | 16,049 | +1.2% |
| 2024 | 16,146 | +0.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6,073 | 3,206 | 8,939 | 10 |
| 2010s | 12,392 | 9,578 | 15,057 | 10 |
| 2020s | 15,852 | 15,555 | 16,146 | 5 |
Countries ranked near Switzerland
More health data for Switzerland
- Un projection of annual infant deaths, annual growth rate -2.13 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.27 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,104 deaths per 1,000 people (2090)
- Number of infants who die before age 1 46 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 1 (2023)
- Population ages 00-04, female, annual growth rate 0.0481 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0233 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.0927 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is reported number of people receiving antiretroviral therapy in Switzerland?
- Reported number of people receiving antiretroviral therapy in Switzerland was 16,146 in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest reported number of people receiving antiretroviral therapy recorded in Switzerland?
- The highest recorded value was 16,146 in 2024.
- What is the lowest reported number of people receiving antiretroviral therapy recorded in Switzerland?
- The lowest recorded value was 3,206 in 2000.
- How does Switzerland rank for reported number of people receiving antiretroviral therapy?
- Switzerland ranks 76th out of 143 countries with data for 2024.
- Is reported number of people receiving antiretroviral therapy rising or falling in Switzerland?
- Over the last ten years it is up 36.3%. The long-run trend across the full record is rising.
- Where does this Switzerland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Reported number of people receiving antiretroviral therapy. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).